Brain network hypersensitivity underlies pain crises in sickle cell disease.
Pangyu Joo, Minkyung Kim, Brianna Kish...
https://pubmed.ncbi.nlm.nih.gov/38538687/Actively Recruiting
Led by University of Cincinnati · Updated on 2026-08-12
120
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating how acupuncture, a non-opioid pain management method, may help relieve pain in patients with sickle cell disease. This study aims to understand both the clinical effectiveness and the brain mechanisms involved in acupuncture analgesia. It is a randomized trial comparing traditional needling acupuncture with laser acupuncture in adolescents and adults aged 14 to 80 years who experience chronic pain or vaso-occlusive crisis related to sickle cell disease. Participants are randomly assigned to one of four groups receiving either needling or laser acupuncture over two different schedules ten sessions twice weekly for 5 weeks or twelve sessions once weekly for 12 weeks. Each session lasts 30 minutes. The treatments target specific acupuncture points using either fine needles or a laser device without skin contact. The study includes 14 visits over 6-8 weeks for treatment and assessments, plus follow-up visits for up to 12 months. During visits, participants undergo questionnaires about health and pain, quantitative sensory testing to assess nervous system function, and brain imaging techniques including MRI, fNIRS, and EEG before and after acupuncture. Pain stimuli are applied during imaging. Female participants have urine pregnancy tests before relevant visits. The study also collects blood samples and inner eyelid images for biomarker analysis. Researchers measure changes in brain connectivity, sensory function, pain levels, psychological status, and quality of life to evaluate acupunctures impact and monitor safety throughout the trial.
CONDITIONS
Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0
Y
Ying Wang, MD, PhD
Y
Ying Wang, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Cincinnati
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Needling Acupuncture for 5 Weeks | Laser Acupuncture for 5 Weeks | Needling Acupuncture for 12 Weeks | Laser Acupuncture for 12 Weeks |
|---|---|---|---|---|
| What it is | Manual acupuncture using main and individualized acupoints chosen based on traditional Chinese medicine diagnosis and tailored to sickle cell pain, provided twice weekly for 5 weeks. | Non-contact laser stimulation at the same acupoints as the needling group, using the VitaLaser 650 device, two times weekly for 5 weeks. | Manual acupuncture as in the 5-week group, with sessions continued twice weekly for 12 weeks. | Laser stimulation as described for the 5-week group, applied at the same points, with sessions extended to 12 weeks. |
| Role in the trial | Investigational intervention to assess the effects of needling acupuncture over a 5-week course. | Investigational comparator arm using laser acupuncture for 5 weeks. | Investigational intervention to evaluate longer duration needling acupuncture for 12 weeks. | Investigational comparator arm using laser acupuncture for a 12-week treatment duration. |
| Primary use in the study | Evaluated for its impact on chronic pain, brain connectivity, sensory testing, and quality of life in sickle cell disease. | Assessed for comparative effects on pain, functional brain imaging findings, and pain-related measures. | Assessed for sustained effects over 12 weeks on pain, brain connectivity, and life quality metrics. | Assessed for sustained, duration-dependent effects on pain outcomes and neuroimaging findings. |
| How it is given or performed | Sterile needles are inserted and manipulated at a tailored set of main and supplementary acupoints across the body by a trained acupuncturist, with each treatment session conducted twice weekly over 5 weeks. | A non-contact laser device is held 1-2cm above the same main and supplementary acupoints, activating them with light instead of needles, twice weekly for 5 weeks. | Acupuncturist-delivered needling at the same main and supplementary acupoints, with sessions continuing twice weekly for a total of 12 weeks. | Non-contact laser device is applied in the same manner as the 5-week group, but sessions occur over 12 weeks. |
| Evidence status | Direct randomized trial evidence is currently limited; prior studies suggest acupuncture may be safe and feasible for pain in sickle cell disease, but robust efficacy data are lacking. | There is limited published evidence for laser acupuncture in sickle cell pain; further data from this trial may help assess its effects. | No published long-term randomized data for 12-week acupuncture in sickle cell disease to date; efficacy remains to be established. | No high-quality data are available for extended-duration laser acupuncture in sickle cell pain; this trial will provide additional evidence. |
| Important limitations | Randomized trial outcomes are not yet available, and the protocol does not compare acupuncture directly with standard-of-care pain management or a usual-care control. | Direct comparison is limited to another investigational acupuncture method, without a standard non-acupuncture pain management arm. | Long-term effects are uncertain, and the lack of standard-care comparison limits interpretability for current practice. | Outcomes are investigational; absence of a non-acupuncture or usual-care group means no direct comparison with standard pain management. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit
Duration - 5 to 12 weeks
Participants receive either needling acupuncture or laser acupuncture sessions lasting 30 minutes each. Treatments occur twice weekly for 5 weeks or once weekly for 12 weeks, totaling 10 or 12 sessions depending on group assignment.
Up to 14 visits over treatment period
Duration - Up to 12 months
Participants complete monthly follow-up visits for up to 12 months after treatment to assess pain, quality of life, and brain function changes.
Monthly visits
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Pangyu Joo, Minkyung Kim, Brianna Kish...
https://pubmed.ncbi.nlm.nih.gov/38538687/Ying Wang, David D Wang, Andrew Q Pucka...
https://pubmed.ncbi.nlm.nih.gov/38249565/Sang Mok Park, Semin Kwon, Yuhyun Ji...
https://pubmed.ncbi.nlm.nih.gov/40465724/Brianna Kish, Jinxia Fiona Yao, Andrew John Frels...
https://pubmed.ncbi.nlm.nih.gov/40800810/Xiaopeng Zhou, Eric Ichesco, Andrew Q Pucka...
https://pubmed.ncbi.nlm.nih.gov/39615812/Ying Wang, Steven J Hardy, Eric Ichesco...
https://pubmed.ncbi.nlm.nih.gov/34418575/Wei Li, Andrew Q Pucka, Candice Debats...
https://pubmed.ncbi.nlm.nih.gov/38361924/University of Cincinnati
Lead Sponsor